Viewing Study NCT03447132


Ignite Creation Date: 2025-12-24 @ 9:26 PM
Ignite Modification Date: 2025-12-25 @ 7:12 PM
Study NCT ID: NCT03447132
Status: COMPLETED
Last Update Posted: 2023-03-10
First Post: 2018-02-11
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Fulvestrant Versus Fulvestrant Plus Palbociclib in Operable Breast Cancer Responding to Fulvestrant
Sponsor: International Cancer Research Group, United Arab Emirates
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module